Insulet (PODD)
(Delayed Data from NSDQ)
$171.40 USD
+2.22 (1.31%)
Updated Mar 28, 2024 04:00 PM ET
After-Market: $171.41 +0.01 (0.01%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth D Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
PODD 171.40 +2.22(1.31%)
Will PODD be a Portfolio Killer in March?
Zacks Investment Research is releasing its prediction for PODD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PODD
Wall Street Analysts See a 38.87% Upside in Insulet (PODD): Can the Stock Really Move This High?
5 Stocks to Buy on the Dip to Gain From the Wall Street Rally
PODD: What are Zacks experts saying now?
Zacks Private Portfolio Services
3 Strong Stocks Down at Least 30% to Buy Now
Here's Why You Should Buy Insulet (PODD) Stock Right Now
Why Insulet (PODD) is a Top Growth Stock for the Long-Term
Other News for PODD
SPY ETF Update, 3/29/2024
Insulet: Insulating Patients, Investors Still Have To Wait
SPY ETF Update, 3/27/2024
Tandem Diabetes raised to Buy at Stifel on Mobi launch
SPY ETF Update, 3/25/2024